Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jan-Heiner Küpper

Showing results (1-10 of 53) with videos related to

Pageof 6
Sort By:
Clinical Hemorheology and Microcirculation|October 24, 2018
Optimized protocol for induction of cytochrome P450 enzymes 1A2 and 3A4 in human primary-like hepatocyte cell strain HepaFH3 to study in vitro toxicologySarah Kammerer, Jan-Heiner Küpper
Clinical Hemorheology and Microcirculation|April 10, 2018
ATP-based cell viability assay is superior to trypan blue exclusion and XTT assay in measuring cytotoxicity of anticancer drugs Taxol and Imatinib, and proteasome inhibitor MG-132 on human hepatoma cell line HepG2Elisabeth Nowak, Sarah Kammerer, Jan-Heiner Küpper
International Journal of Molecular Sciences|December 2, 2020
Effect of Prostanoids on Human Platelet Function: An OverviewSteffen Braune, Jan-Heiner Küpper, Friedrich Jung
Clinical Hemorheology and Microcirculation|September 29, 2019
NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studiesChristian Schulz, Sarah Kammerer, Jan-Heiner Küpper
Clinical Hemorheology and Microcirculation|September 6, 2021
Inhibition of phase-1 biotransformation and cytostatic effects of diphenyleneiodonium on hepatoblastoma cell line HepG2 and a CYP3A4-overexpressing HepG2 cell cloneChristian Schulz, Friedrich Jung, Jan-Heiner Küpper
International Journal of Molecular Sciences|May 14, 2025
Mono-CYP CHO Model: A Recombinant Chinese Hamster Ovary Cell Platform for Investigating CYP-Specific Tamoxifen MetabolismChristian Schulz, Sarah Stegen, Friedrich Jung, et al.
Archives of Toxicology|September 10, 2020
Structure-dependent genotoxic potencies of selected pyrrolizidine alkaloids in metabolically competent HepG2 cellsLukas Rutz, Lan Gao, Jan-Heiner Küpper, et al.
European Journal of Biochemistry|January 11, 2002
Early growth response-1 gene (Egr-1) promoter induction by ionizing radiation in U87 malignant glioma cells in vitroRalph G Meyer, Jan-Heiner Küpper, Reinhard Kandolf, et al.
Clinical Hemorheology and Microcirculation|August 28, 2023
In vitro simulation of the liver first-pass effect with biotransformation-competent HepG2 cells to study effects of MG-132 on liver and cancer cellsSarah Kammerer, Elisabeth Nowak, René Mantke, et al.
Toxicology|August 28, 2020
Estragole: DNA adduct formation in primary rat hepatocytes and genotoxic potential in HepG2-CYP1A2 cellsRuth Schulte-Hubbert, Jan-Heiner Küpper, Adam D Thomas, et al.
Pageof 6

Showing results (1-10 of 53) with videos related to

Sort By:
Pageof 6
Clinical Hemorheology and Microcirculation|October 24, 2018
Optimized protocol for induction of cytochrome P450 enzymes 1A2 and 3A4 in human primary-like hepatocyte cell strain HepaFH3 to study in vitro toxicologySarah Kammerer, Jan-Heiner Küpper
Clinical Hemorheology and Microcirculation|April 10, 2018
ATP-based cell viability assay is superior to trypan blue exclusion and XTT assay in measuring cytotoxicity of anticancer drugs Taxol and Imatinib, and proteasome inhibitor MG-132 on human hepatoma cell line HepG2Elisabeth Nowak, Sarah Kammerer, Jan-Heiner Küpper
International Journal of Molecular Sciences|December 2, 2020
Effect of Prostanoids on Human Platelet Function: An OverviewSteffen Braune, Jan-Heiner Küpper, Friedrich Jung
Clinical Hemorheology and Microcirculation|September 29, 2019
NADPH-cytochrome P450 reductase expression and enzymatic activity in primary-like human hepatocytes and HepG2 cells for in vitro biotransformation studiesChristian Schulz, Sarah Kammerer, Jan-Heiner Küpper
Clinical Hemorheology and Microcirculation|September 6, 2021
Inhibition of phase-1 biotransformation and cytostatic effects of diphenyleneiodonium on hepatoblastoma cell line HepG2 and a CYP3A4-overexpressing HepG2 cell cloneChristian Schulz, Friedrich Jung, Jan-Heiner Küpper
International Journal of Molecular Sciences|May 14, 2025
Mono-CYP CHO Model: A Recombinant Chinese Hamster Ovary Cell Platform for Investigating CYP-Specific Tamoxifen MetabolismChristian Schulz, Sarah Stegen, Friedrich Jung, et al.
Archives of Toxicology|September 10, 2020
Structure-dependent genotoxic potencies of selected pyrrolizidine alkaloids in metabolically competent HepG2 cellsLukas Rutz, Lan Gao, Jan-Heiner Küpper, et al.
European Journal of Biochemistry|January 11, 2002
Early growth response-1 gene (Egr-1) promoter induction by ionizing radiation in U87 malignant glioma cells in vitroRalph G Meyer, Jan-Heiner Küpper, Reinhard Kandolf, et al.
Clinical Hemorheology and Microcirculation|August 28, 2023
In vitro simulation of the liver first-pass effect with biotransformation-competent HepG2 cells to study effects of MG-132 on liver and cancer cellsSarah Kammerer, Elisabeth Nowak, René Mantke, et al.
Toxicology|August 28, 2020
Estragole: DNA adduct formation in primary rat hepatocytes and genotoxic potential in HepG2-CYP1A2 cellsRuth Schulte-Hubbert, Jan-Heiner Küpper, Adam D Thomas, et al.
Pageof 6